Annex

Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:

1. (1)

   in Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein:

   ‘

   1,2-dichloropropane; propylene dichloride	602-020-00-0	201-152-2	78-87-5
   e-glass microfibers of representative composition; [Calcium-aluminium-silicate fibres with random orientation with the following representative composition (% given by weight): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).]	014-046-00-4	—	—

   ’

2. (2)

   in Appendix 4, the following entry is inserted in the table in order of the index number set out therein:

   ‘

   3,7-dimethylocta-2,6-dienenitrile

   608-067-00-3

   225-918-0

   5146-66-7

   ’

3. (3)

   in Appendix 5,

   1. (a)

      the following entries are inserted in the table in order of the index numbers set out therein:

      ‘

      brodifacoum (ISO); 4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin	607-172-00-1	259-980-5	56073-10-0
      lead powder; [particle diameter < 1 mm]	082-013-00-1	231-100-4	7439-92-1
      lead massive: [particle diameter ≥ 1 mm]	082-014-00-7	231-100-4	7439-92-1

      ’

   2. (b)

      the entry relating to warfarin; 4-hydroxy-3-(3-oxo-1- phenylbutyl)-coumarin is replaced by the following entry:

      ‘

      warfarin (ISO); 4-hydroxy-3-(3-oxo-1- phenylbutyl)-2H-chromen-2-one; [1] (S)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone; [2] (R)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone [3]

      607-056-00-0

      201-377-6 [1] 226-907-3 [2] 226-908-9 [3]

      81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3]

      ’

4. (4)

   in Appendix 6,

   1. (a)

      the following entries are inserted in the table in order of the index numbers set out therein:

      ‘

      tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol	603-061-00-7	202-625-6	97-99-4
      gallium arsenide	031-001-00-4	215-114-8	1303-00-0
      Tributyltin compounds, with the exception of those specified elsewhere in this Annex	050-008-00-3	—	—
      1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear	607-710-00-5	271-093-5	68515-50-4
      imidazole	613-319-00-0	206-019-2	288-32-4
      bisphenol A; 4,4′-isopropylidenediphenol	604-030-00-0	201-245-8	80-05-7
      phenol, dodecyl-, branched; [1] phenol, 2-dodecyl-, branched; [2] phenol, 3-dodecyl-, branched; [3] phenol, 4-dodecyl-, branched; [4] phenol, (tetrapropenyl) derivatives [5]	604-092-00-9	310-154-3 [1] - [2] - [3] - [4] - [5]	121158-58-5 [1] - [2] - [3] 210555-94-5 [4] 74499-35-7 [5]
      chlorophacinone (ISO);2-[(4-chlorophenyl)(phenyl)acetyl]-1H-indene-1,3(2H)-dione	606-014-00-9	223-003-0	3691-35-8
      coumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin	607-059-00-7	227-424-0	5836-29-3
      difenacoum (ISO); 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin	607-157-00-X	259-978-4	56073-07-5
      flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin	607-375-00-5	421-960-0	90035-08-8
      disodium octaborate anhydrous; [1] disodium octaborate tetrahydrate [2]	005-020-00-3	234-541-0 [1] 234-541-0 [2]	12008-41-2 [1] 12280-03-4 [2]
      bromadiolone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-one	607-716-00-8	249-205-9	28772-56-7
      difethialone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-one	607-717-00-3	—	104653-34-1
      perfluorononan-1-oic acid [1] and its sodium [2] and ammonium [3] salts	607-718-00-9	206-801-3 [1] - [2] - [3]	375-95-1 [1] 21049-39-8 [2] 4149-60-4 [3]
      dicyclohexyl phthalate	607-719-00-4	201-545-9	84-61-7
      triflumizole (ISO); (1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine	612-289-00-6	—	68694-11-1

      ’

   2. (b)

      the entry relating to flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl)—2,H 1,4-benzoxazin-6-yl) cyclohex-1-ene-1,2dicarboxamide is replaced by the following entry:

      ‘

      flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione

      613-166-00-X

      —

      103361-09-7

      ’